Human papillomavirus (HPV) vaccination and subsequent sexual behaviour: Evidence from a large survey of Nordic women

Vaccine

Volumn 32, Issue 39, 2014, Pages 4945-4953

  Hansen, Bo T ^a   Kjær, Susanne K ^b,c   Arnheim Dahlström, Lisen ^d   Liaw, Kai Li ^e   Jensen, Kirsten E ^b   Thomsen, Louise T ^b   Munk, Christian ^b   Nygård, Mari ^a  

^a Department of Research Cancer Registry of Norway ^*  (Norway)

^b DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

^d KAROLINSKA INSTITUTE   (Sweden)

^e MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Adolescent health; Cervical cancer; First intercourse; HPV; Risk compensation; Sexual behaviour

Indexed keywords

WART VIRUS VACCINE;

ADULT; AGE DISTRIBUTION; ARTICLE; CONTRACEPTION; CROSS-SECTIONAL STUDY; DENMARK; FEMALE; GRAFT RECIPIENT; HIGH RISK BEHAVIOR; HUMAN; MAJOR CLINICAL STUDY; MIDDLE AGED; NORWAY; PRIORITY JOURNAL; SELF REPORT; SEXUAL BEHAVIOR; SEXUAL INTERCOURSE; SEXUALITY; SWEDEN; VACCINATION; YOUNG ADULT; ADOLESCENT; PAPILLOMAVIRUS INFECTIONS; PROPORTIONAL HAZARDS MODEL; RISK; STATISTICS AND NUMERICAL DATA;

ADOLESCENT; ADULT; CROSS-SECTIONAL STUDIES; DENMARK; FEMALE; HUMANS; MIDDLE AGED; NORWAY; ODDS RATIO; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; PROPORTIONAL HAZARDS MODELS; RISK-TAKING; SEXUAL BEHAVIOR; SWEDEN; VACCINATION; YOUNG ADULT;

EID: 84906090443     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2014.07.025     Document Type: Article

References (33)

1. Bosch F.X., Lorincz A., Munoz N., Meijer C.J., Shah K.V. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 2002, 55:244-265.
2. Aubin F., Pretet J.L., Jacquard A.C., Saunier M., Carcopino X., Jaroud F., et al. Human papillomavirus genotype distribution in external acuminata condylomata: a large French national study (EDiTH IV). Clin Infect Dis 2008, 47:610-615.
3. Villa L., Perez G., Kjaer S., Lehtinen M., Paavonen J., Munoz N., et al. Effect of prophylactic human papillomavirus L1 virus-like-particle vaccine on risk of cervical intraepithelial neoplasia grade 2, grade 3, and adenocarcinoma in situ: a combined analysis of four randomised clinical trials. Lancet 2007, 369:1861-1868.
4. Paavonen J., Naud P., Salmeron J., Wheeler C.M., Chow S.N., Apter D., et al. Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women. Lancet 2009, 374:301-314.
5. Leval A., Herweijer E., Ploner A., Eloranta S., Fridman Simard J., Dillner J., et al. Quadrivalent human papillomavirus vaccine effectiveness: a Swedish national cohort study. J Nat Cancer Inst 2013, 105:469-474.
6. Baandrup L., Blomberg M., Dehlendorff C., Sand C., Andersen K.K., Kjaer S.K. Significant decrease in the incidence of genital warts in young Danish women after implementation of a national human papillomavirus vaccination program. Sex Transm Dis 2013, 40:130-135.
7. Waller J., Marlow L.A.V., Wardle J. Mothers' attitudes towards preventing cervical cancer through human papillomavirus vaccination: a qualitative study. Cancer Epidemiol, Biomarkers Prev 2006, 15:1257-1261.
8. Marlow L.A.V., Forster A.S., Wardle J., Waller J. Mothers' and adolescents' beliefs about risk compensation following HPV vaccination. J Adolesc Health 2009, 44:446-451.
9. Hilton S., Hunt K., Langan M., Bedford H., Petticrew M. Newsprint media representations of the introduction of the HPV vaccination programme for cervical cancer prevention in the UK (2005-2008). Soc Sci Med 2010, 70:942-950.
10. Wilde G.J.S. Accident countermeasures and behavioral compensation-the position of risk homeostasis theory. J Occup Accid 1989, 10:267-292.
11. Brewer N.T., Cuite C.L., Herrington J.E., Weinstein N.D. Risk compensation and vaccination: can getting vaccinated cause people to engage in risky behaviors. Ann Behav Med 2007, 34:95-99.
12. Forster A.S., Marlow L.A.V., Waller J. Adolescents' beliefs about their parents' human papillomavirus vaccination decisions. Bjog-Int J Obstet Gy 2010, 117:229-233.
13. Dahlstrom L.A., Tran T.N., Lundholm C., Young C., Sundstrom K., Sparen P. Attitudes to HPV vaccination among parents of children aged 12-15 years-a population-based survey in Sweden. Int J Cancer 2010, 126:500-507.
14. Marlow L.A.V., Waller J., Wardle J. Parental attitudes to pre-pubertal HPV vaccination. Vaccine 2007, 25:1945-1952.
15. Sundstrom K., Tran T.N., Lundholm C., Young C., Sparen P., Dahlstrom L.A. Acceptability of HPV vaccination among young adults aged 18-30 years-a population based survey in Sweden. Vaccine 2010, 28:7492-7500.
16. Mullins T.L.K., Zimet G.D., Rosenthal S.L., Morrow C., Ding L.L., Shew M., et al. Adolescent perceptions of risk and need for safer sexual behaviors after first human papillomavirus vaccination. Arch Pediatr Adolesc Med 2012, 166:82-88.
17. Cummings T., Zimet G.D., Brown D., Tu W., Yang Z., Fortenberry J.D., et al. Reduction of HPV infections through vaccination among at-risk urban adolescents. Vaccine 2012, 30:5496-5499.
18. Forster A.S., Marlow L.A.V., Stephenson J., Wardle J., Waller J. Human papillomavirus vaccination and sexual behaviour: cross-sectional and longitudinal surveys conducted in England. Vaccine 2012, 30:4939-4944.
19. Mather T., McCaffery K., Juraskova I. Does HPV vaccination affect women's attitudes to cervical cancer screening and safe sexual behaviour. Vaccine 2012, 30:3196-3201.
20. Liddon N.C., Leichliter J.S., Markowitz L.E. Human papillomavirus vaccine and sexual behavior among adolescent and young women. Am J Prev Med 2012, 42:44-52.
21. Marchand E., Glenn B.A., Bastani R. HPV vaccination and sexual behavior in a community college sample. J Commun Health 2013, 38:1010-1014.
22. Ratanasiripong N.T. Human papillomavirus vaccine increases high-risk sexual behaviors: a myth or valid concern. J Sch Nurs 2014, 1-8.
23. Bednarczyk R.A., Davis R., Ault K., Orenstein W., Omer S.B. Sexual activity-related outcomes after human papillomavirus vaccination of 11- to 12-year-olds. Pediatrics 2012, 130:798-805.
24. Pedersen C.B., Gotzsche H., Moller J.O., Mortensen P.B. The Danish civil registration system-a cohort of eight million persons. Dan Med Bull 2006, 53:441-449.
25. Ludvigsson J.F., Otterblad-Olausson P., Pettersson B.U., Ekbom A. The Swedish personal identity number: possibilities and pitfalls in healthcare and medical research. Eur J Epidemiol 2009, 24:659-667.
26. Sander B.B., Rebolj M., Valentiner-Branth P., Lynge E. Introduction of human papillomavirus vaccination in Nordic countries. Vaccine 2012, 30:1425-1433.
27. Efron B. Efficiency of Coxs likelihood function for censored data. J Am Stat Assoc 1977, 72:557-565.
28. Agresti A. Categorical data analysis 2002, Wiley, New York, NY. 2nd ed.
29. R Core Team R: a language and environment for statistical computing 2013, R Core Team, Vienna, Austria.
30. Statens Serum Institut HPV vaccination coverage 2012 2013, 20. Epi-News, Available from: 〈http://www.ssi.dk/English/News/EPI-NEWS/2013/No%2020%20-%202013.aspx〉.
31. Jensen K.E., Munk C., Sparen P., Tryggvadottir L., Liaw K.L., Dasbach E., et al. Women's sexual behavior. Population-based study among 65,000 women from four Nordic countries before introduction of human papillomavirus vaccination. Acta Obstet Gynecol Scand 2011, 90:459-467.
32. Stigum H., Samuelsen S.O., Traeen B. Analysis of first coitus. Arch Sex Behav 2010, 39:907-914.
33. Siegel D.M., Aten M.J., Roghmann K.J. Self-reported honesty among middle and high school students responding to a sexual behavior questionnaire. J Adolesc Health 1998, 23:20-28.